Life Sciences Queensland Limited Quarterly Newsletter ...€¦ · Life Sciences Queensland Limited...

Life Sciences Queensland Limited Your other life partner

Life Sciences Queensland LimitedQuarterly Newsletter - June 2014

Email: [email protected]: +61 7 3331 3999

Address: Level 3, 88 Jephson St, Toowong,QLD 4066 AUSTRALIA.

www.lsq.com.au 2Email: [email protected]

Telephone: +61 7 3331 3999Address: Level 3, 88 Jephson St, Toowong,

QLD 4066 AUSTRALIA.

www.lsq.com.au 2

Welcome to the June LSQ Quarterly Newsletter. As

many of you will know, we’ve been kept busy this past

quarter, and it is my pleasure to provide you with a brief

overview of our activities, events and highlights.

We’ve hosted numerous industry events and been

involved with a number of key activities recently,

resulting in positive outcomes, including strengthening

of international relationships and collaborations.

As you may be aware, early March saw LSQ travel

to the USA on the Premier’s Mission, where I was

pleased to represent the life sciences as a part of

the Queensland Delegation. I attended the official

opening of the Trade and Investment Queensland

office in Houston, Texas; and am pleased that we

once again have a representation in North America.

Both Queensland and Texas enjoy the status of being

the high growth states of Australia and the USA

respectively, and the people of both states have a can

do attitude.

We held Life Sciences in Parliament (LSIP) 2014

in April, providing an important opportunity for our

Members and industry stakeholders to engage

with government officials to discuss the industry, its

opportunities and challenges.

In late April, LSQ marked a milestone of ten years of

supporting the NZBIO conference with the signing of

an MoU. I was pleased to see an actively engaged

Queensland stakeholder presence at the event.

Speaking of active Members, I continue to be

involved with many Member’s events to celebrate

their development, achievements and collaborations;

including the 250+ who participated in the Life

Sciences @ UQ forum on 12 June. You will find images

and news on many of these activities mentioned in the

Newsletter. It’s great to reflect on our Members and the

industry’s achievements, collaborations and outcomes

as a reminder of the hard work and determination that

is a hallmark of so many of our colleagues.

Of course the recent Federal and State budgets have

been a topic of conversation amongst many industry

sectors. We welcome the news that the proposed

$20 billion Future Fund in the Federal Budget is to be devoted to medical research, and encourage the Government to also look at enabling programs to ensure that the knowledge derived from the Fund’s investments will be able to be taken to successful outcomes.

We also were very pleased to see the Queensland State Government announce that it will use some of the proceeds of asset sales to create a $500 M Entrepreneurial and Innovation Fund. While it is too early for details around the fund, we are working closely with the Minister to understand how it might be structured and utilised in order to provide the greatest benefits to Queensland.

You may have also heard of the “Strong Choices Program” – I strongly encourage all of our industry stakeholders to get involved and visit the “Strong Choices” website here to ensure there is clear and strong support for the E & I Fund.

We will support the Queensland Delegation at DIA and BIO in two weeks. It is clear that our Members recognise the importance of these leading international events as key to finding partners, developing projects and showcasing outcomes for strong economic, cultural and business ties. We have a significant delegation travelling to the USA in June (at the time of writing we are almost at 80), and I am looking forward to what I’m sure will be another year of positive outcomes and initiatives for our delegates.

LSQ has started to make plans around a number of upcoming events such as RQA’s Quality Systems for Research Laboratories Course; AusBiotech 2014, Collaborate to Innovate; and the Premier’s Innovation Award; as well as our own GENE, TRX14 and I-20 events. The I-20 draft program and some of the key note speakers have now been released to the G20 representatives and registrations open soon. Keep an eye out for updates and calls to action for each of these events and also for our new Jewels Program.

WELCOME



www.lsq.com.au 3

INDUSTRY highlightsIn recent industry news, LSQ congratulated Professor Maree Smith on her key involvement in the development of a chronic pain relief drug; and LSQ Chairman Dr Peter Riddles on his new appointment with the CSIRO. We said thank you and farewell to a long-serving Trade & Investment Queensland business development leader and welcomed three new LSQ Board Members.

Congratulations to Spinifex Pharmaceutical Pty Ltd - founded by

UniQuest in 2005 - who announced recently it has attracted US$45

million (AU$48 million) to advance development of a chronic pain

treatment drug - EMA401.

LSQ CEO Mr Mario Pennisi commended the investment and noted

the key involvement of a Queensland Industry stalwart, Professor

Maree Smith.

“This investment by Novo A/S and Canaan Partners reflects the great work of the Spinifex

team who have built on the high quality, world class science and research by Professor

Maree Smith and the team at the University of Queensland (UQ),” Mr Pennisi said.

Source - click here. Image: Prof. Maree Smith.

LSQ congratulates Spinifex and Professor Maree Smith on AU$48m funding

Prominent Queensland biotechnologist, Dr Peter Riddles, has been

appointed a part-time member of the Commonwealth Scientific and

Industrial Research Organisation (CSIRO) Board.

Minister for Industry Ian Macfarlane said Dr Riddles’ experience and

expertise in biotechnology in both the higher education and research

sectors will be of great value to the CSIRO, Australia’s national science

agency.

“Dr Riddles’ board experience across the life sciences including working on commercialisation

and new venture creation, and on policy development and strategy with governments, will

complement the existing skills and expertise of the CSIRO Board,” Mr Macfarlane said.

Dr Riddles is a board director and consultant including Chairman to Life Sciences

Queensland Ltd. His career includes working in the private sector, with government bodies

and research institutions. Source - click here. Image: Dr Peter Riddles.

New appointment strengthens CSIRO Board

Brisbane:

Home of

the G20

http://online.speedmarketing.com.au/download/files/44272/1735641/LSQ%20Congratulates%20Spinifex%20and%20Professor%20Maree%20Smith%20on%20AU_48m%20F.pdf

http://www.minister.industry.gov.au/ministers/macfarlane/media-releases/new-appointment-strengthens-csiro-board

www.i-20.com.au



www.lsq.com.au 4

Biopharmaceuticals Australia (BPA)

recently began providing support to

biopharmaceutical product developers

wanting to make use of their state-of-the-

art mammalian cell GMP manufacturing

facility, operated by BPA’s comemercial

partner Patheon Biologics (formerly DSM

Biologics) through its new Biophamaceutical

Development Fund (BDF).

The BDF aims to support the development

of therapeutic proteins generated in

mammalian cell culture - from the pre-

clinical stage through to approved drug

products. A BDF grant will allow financially

constrained entities with biodrug prospects

to accelerate their commercial translation by

co-funding access to pivotal development

services. The second funding round is open

for applications, and closes on July 31st..

To learn more or apply for funding, please

visit the BPA website here.

Patheon Biologics also recently won the coveted International Society for Pharmaceutical Engineering (ISPE) “Facility of the Year” award for the GMP Manufacturing Facility, in the Process Innovation category.

The award is a major achievement and a testament to Patheon’s world-class and industry-leading process technologies. It is also significant for BPA, who funded and managed the design and construction phases of the Facility, as it places the project as one of the top six in the world completed in 2013.

CEO of BPA, David Hughes said “I am extremely proud of the integrated efforts of the key players involved in the design and delivery of the project, which was completed on-time and on-budget. Such an outstanding result is a compliment to all the team.”

Biopharmaceuticals Australia in the Spotlight

TranslationalResearch Excellence24 October 2014 | Brisbane, Australia.

http://www.biopharmaus.com.au/bdf/

[email protected]



www.lsq.com.au 5

LSQ has recently appointed three new

Board Members; Dr Stuart Hazell, Managing

Director, Fusidium Pty Ltd; Professor

Brandon Wainwright, Director, Institute

for Molecular Bioscience (IMB) and Dr

Tracie Ramsdale, Non-Executive Director,

Alchemia. Stuart, Tracie and Brandon join

inaugural LSQ Board Members Dr Peter

Riddles of Vicibio; Ms Winna Brown of EY

and Mr Michael McArdle of Queensland

University of Technology.

Stuart has more than 35 years’ experience

in the life sciences industry, including

biomedical research, publishing,

consultancy and senior management roles

in the public and private sectors.

“I’ve worked with LSQ for a number of

years now and was a part of the Steering

Committee to establish it,” Stuart said.

“I’m pleased to have joined the Board –

LSQ is a great and valuable body for the

representation and development of the

Queensland biosciences industry.”

Brandon was appointed Director of IMB in

2006, and is committed to translating high

quality research

into outcomes,

with his own

research being

supported by

a number of

B io techno logy

companies.

“Queensland state

is leading Australia

in the application

of the life sciences

to create health

and wealth for all

Queenslanders

in areas ranging

from new

pharmaceutics

to improved

agriculture and

sustainable fuel

production,”

Brandon said.

“LSQ is playing a

key role in facilitating this rapid growth of

the Bioeconomy in Queensland and I look

forward to being included in the creation of

a new pillar for our economy and future with

LSQ.”

Tracie holds a number of roles within the

industry and currently provides independent

consulting advice in the biotechnology,

academia and government sectors.

“Each individual is a valuable addition to the

LSQ Board and utilising their varied industry

knowledge will help shape the strategic

direction of the organisation,” said LSQ

CEO Mario Pennisi.

Images: (L) Dr Ramsdale; (R top) Prof.

Wainwright; (R bottom) Dr Hazell.

New LSQ Board Members appointed

RQA with the support of LSQ, will deliver a highly valuable two-day course led by leading

international tutors Stephen Volsen and Louise Handy in October 2014. The highly interactive

course is designed for those involved in the research quality arena, tailored to meet the needs of

scientific management, bench scientists and quality professionals alike. LSQ and RQA Member

rates apply. For more details and to register, please click here, or contact [email protected]

Quality Systems for Research Laboratories Course 22 - 23 October 2014 | Brisbane, Queensland

http://www.therqa.com/courses/c5602-quality-systems-for-research-laboratories/



www.lsq.com.au 6

Nominations are open for the following GENE Awards:

• McCullough Robertson LSQ Industry Excellence Award

• LSQ Elected Officials Award

• LSQ Trade Commissioners Award

The awards will be presented at the 2014 Globally Engaging

Networking Event on 17th October this year. Click here to view GENE

Award details and download a nomination form.

Nominate for the 2014 GENE Awards

In response to market demand Bellberry Ltd is opening its doors in Queensland.

Founded in 2004, the private Not For Profit organisation provides an independent and streamlined ethical and scientific review service to a broad spectrum of the research community Australia-wide. Research projects range from large, sponsored, multi-centre clinical trials to independent investigator-led medical research and the social sciences.

With certified HREC meetings taking place 5 times a month, Bellberry is able to offer a streamlined approach to ethics review with an average turnaround time of less than 3 weeks. Surpluses from the process are put back into the medical research community, with the Australian Institute of Health and Tropical Medicine at James Cook University being a recipient in 2013.

“Queensland is a strong and vibrant environment for clinical research,” says Bellberry CEO Kylie Sproston. “We look forward to forging new links with research professionals and institutions in the state and to further strengthening existing relationships.”

Image: Bellberry CEO, Kylie

Sproston.

Growing demand for review services indicates healthy Clinical Research environment

In April, LSQ hosted a farewell dinner for Takako Kaneyasu, Trade & Investment Queensland

business develoment manager, after 34 years of loyal service to the people of Queensland.

Ms Kaneyasu has served Queensland’s life sciences industry and international trade

industry under 8 different State Premiers.

Ms Kaneyasu’s effort in market to assist and

promote LSQ Members and attract life sciences

industry business into Queensland was recognised

in 2013 with the presentation of the LSQ Trade

Commissioner’s Award at the Globally Engaging

Networking Event (GENE).

LSQ farewells TIQ’s Takako Kaneyasu

http://www.trx14.com.au/GENE/tabid/364/Default.aspx





QLD 4066 AUSTRALIA.

www.lsq.com.au 7

NEWS & EVENTS Wrap UpIf you haven’t checked out the LSQ website’s event photos page recently, scroll here to get an overview of event highlights and activities we’ve hosted or attended.

U.S. Premier’s Mission8-9 March

Read more about the opening of Trade & Investment Queensland in Texas on page 8.

>>

http://www.lsq.com.au/Events/Photos.aspx





QLD 4066 AUSTRALIA.

www.lsq.com.au 8

LSQ attended the official opening of

the Trade and Investment Queensland

office in Houston as a part of the

Queensland delegation on the USA

trade mission led by the Honorable

Premier Campbell Newman, Premier

of Queensland, Trade and Investment

Queensland’s Trade Commissioner,

David Camerlengo and CEO, Andrew

Tulloch earlier this month. The office

opening was conducted on March

12th by the Honorable Rick Perry,

Governor of Texas and Premier

Newman; and was attended by more

than 150 guests in Houston, Texas.

The signing of a sister state agreement

also took place at the event, in which

Governor Perry and Premier Newman

acknowledged the already strong

relationship between Queensland and

Texas including economic, business,

academic and cultural ties.

Trade & Investment Queensland opens in Texas

Industry Breakfast with Jeff Bleich 28 March





QLD 4066 AUSTRALIA.

www.lsq.com.au 9

Life Sciences Industry in Parliament 2014 3 April

LSIP 2014 was well received. Minister Walker announced

he will be attending BIO 2014 in June, and mentioned

BPA’s new $2 million Biopharmaceutical Development

Fund. The event provided an informing and compelling

overview of the life sciences and the issues it faces,

and there was great representation from

Members of Parliament.

We’re already preparing for LSIP 2015!

Life Sciences Industry in Parliament 2014

These are some of the faces of Queensland’s life sciences industry.

How many of them do you know?





QLD 4066 AUSTRALIA.

www.lsq.com.au 11

NZBIO 201429 April

LSQ recently exhibited at NZBIO 2014 for its tenth

consecutive year with a strong Queensland stakeholder

presence including LSQ Members BioPharmaceuticals

Australia, ERA Consulting and Agritechnology. The event

was vibrant and upbeat, and attended by more than 200

delegates.

Ten years of a strong Queensland presence and ongoing

interaction were marked by the signing of a Memorandum

of Understanding between LSQ and NZBIO.

LSQ CEO Mario Pennisi said the MoU formalises the

close working relationship that Queensland and New

Zealand have enjoyed, and takes the original Queensland

Government and New Zealand Government MoU to a

new phase of industry investment.

Queensland-NZBIO alliance recognised with MoU

Image: courtesy NZBIO 2014>>

Eskitis Nature Bank Sponsor-a-Sample Launch

1 May

Read more about the Sponsor-a-Sample launch on page 12.

>>





QLD 4066 AUSTRALIA.

www.lsq.com.au 12

UQ IMB Collaboration & Industry Engagement event with Professor Mark Dodgson 9 May

Last week LSQ attended the official launch of the Eskitis Institute’s Sponsor a Sample campaign in which everyone has the opportunity to take on the role of a medical researcher.

Eskitis Foundation Board member Mrs Terri Irwin officially launched the campaign and handed over $100 to “adopt” one of the samples stored in Nature Bank, a collection of more than 45,000 plants and marine invertebrates.

Scientists at Griffith University’s Eskitis Institute for Drug Discovery test these samples to see if they have within them compounds that could be the key to beating some of the world’s most debilitating diseases, including malaria, cancer, Parkinson’s disease, HIV and Alzheimer’s.

Terri was delighted to launch the campaign and she is looking forward to Eskitis Institute researchers coming to the Steve Irwin Wildlife Reserve in Cape York to continue their collection work.

“How cool would it be if your sample was the one that worked; if it was the one that led to a cure for cancer?” she said.

Terri Irwin joins fight against disease

Image: courtesy Griffith University

>>





QLD 4066 AUSTRALIA.

www.lsq.com.au 13

LSQ-QUT WCIB Reception12 May

World Congress on Industrial Biotechnology 2014 12-15 May



www.lsq.com.au 14

Northern Australia has vast potential for development. Just one proposed agriculture project of the many that I’m currently aware of would cover an area as big as metropolitan Brisbane, Australia’s third largest city.

Other single farms could be as large or larger than the entire Ord River scheme in Western Australia, home to mainland Australia’s biggest freshwater dam at Lake Argyle, which can store roughly 20 times the water in Sydney Harbour.

Those are just some of the major projects on the drawing board for northern Australia, which have attracted the interest not only of Australian investors, but also investors from the US and China. Such foreign investment will be crucial to what happens over the next few decades in places such as the Flinders and Gilbert river catchments in north Queensland.

But with vast potential also comes vast, and as yet not entirely well-understood, challenges. For instance, how do we fund the infrastructure to capture, store and distribute the water from the wet season to support agriculture all year round? And where are the most appropriate places to build proposed new water storages?

Those are some of the questions being asked again, with the federal government this week asking for public comment on its new Green Paper on Developing Northern Australia. The paper is a precursor to a new national policy for our north.

Released this week by Deputy Prime Minister Warren Truss, the green paper is a good start in the process of developing a plan for the north.

The risk to successful development in the north is in underestimating both the scale of the opportunity and the scale and complexity of the challenges. Many past attempts at development have failed on both these counts.

So there is much work still to be done before being able to predict if this new push to develop northern Australia will succeed where past plans have failed.

Economies of scale

If Australia’s new national policy for developing northern Australia is to get anywhere, one of the most important issues for it to address is the huge scale of investment required to get major new projects off the ground.

We also need to define the paths to winning a significant share of high-value Asian markets.

The green paper suggests the northern economy should be diversified into areas other than mining and energy. Tourism and agriculture — and I’ll largely focus on agriculture, as it’s my area of expertise — are the two main options identified.

Some past failures in agriculture in the north can be attributed in transplanting agricultural technology from the south, rather than re-inventing it for the new northern environment.

Globally we have had much more research and development delivering technology into temperate agriculture rather than tropical agriculture, where we now have the greatest need in Australia and globally.

Australian research and development capability in this area is strong, and should provide a competitive advantage in developing our north, one of the few remaining areas in the world with potential for agricultural expansion.

Giant steps needed to build up northern Australia’s potential An article by Professor Robert Henry from The Conversation

An Ord River sandalwood plantation near Kununurra



www.lsq.com.au 15

Working with local conditions

The green paper cautiously does not attempt to pick winners in backing specific industries.

Agriculture in the north may continue to depend upon the established industries such as beef for some time, but new agricultural ventures will have a wide range of options, requiring careful evaluation. Agricultural and food products that can thrive in northern Australian conditions need to be identified.

The scale of investment is a big challenge. For example, establishing new farms in remote northern locations could require new roads and rail to get the products to a port or market.

As the Deputy Prime Minister noted this week, water storage and distribution systems may need to be constructed. But new dams aren’t cheap, meaning large-scale investments would be needed.

Single farms as big as the entire Ord River scheme or possibly even larger are now being considered. That has major implications for the policies that need to be developed by government to attract large-scale investment.

Businesses of this type might resort to a fly-in, fly-out workforce, following the mining industry’s example. But the social implications of fly-in, fly out farming need to be better understood.

Investing in success

Development of the north will require that governments at all levels create an investment environment that will attract the significant capital essential for new ventures in the north. That means getting the balance right between removing red tape and ensuring investment in sustainable industries.

A key to success for Australian agriculture will be in successfully targeting high-value niche markets for food products in Asia.

These Asian markets are large and — despite the niche label — are able to take all that Australia can produce of most foods, as I’ve written about for The Conversation before. Niche markets tend to pay higher prices, but they may also be highly competitive and require sophisticated marketing and quality control.

But rather than just producing food and then exporting it for others to process further, on-farm processing in northern Australia is likely to be essential to many businesses.

We’re not talking about small, family-run farms, but big businesses, covering bigger areas and able to capture greater economies of scale.

Alongside business, Australian scientists will have a key role in delivering the appropriate new crops, new animals and new farming systems that will be necessary for agriculture

to succeed in the north.

Developing more remote areas of northern Australia comes with bigger challenges than setting up new ventures in established areas like the Murray-Darling region.

But the opportunities are there. Now we need to ensure that government policy settings and business plans are well-targeted, so that developing northern Australia finally moves on from being a long-held dream to becoming a reality.

Source - click here.Ord, Flinders and Gilbert river regions, Northern Australia

http://theconversation.com/giant-steps-needed-to-build-up-northern-australias-potential-27787



www.lsq.com.au 16

Life Sciences Jobs and Career Board

Experienced CFO - Healthcare/Technology

A chartered accountant with over 15 years post qualification experience gained within Australia and Ireland/UK in senior finance roles with leading international organisation across the healthcare technology, telecoms, pharmaceutical and construction sectors. Now seeking his next career move within healthcare technology or into the biotechnology industry.

Key strengths are:

• Strong analytical, strategic and management skills.

• Ability to integrate the finance function into the operational decision making and strategic management processes.

• Streamlining reporting, forecasting and budgeting processes to provide analysis and insight of real value to the business.

• Adept at identifying cost saving opportunities and managing complex cost saving projects to completion.

• Effective manager of systems implementations and team building including the ability to identify and cultivate key people, strengthen skill-sets and improve morale.

• A record in setting goals that are specific, measurable and achievable, and driving a result orientated finance function and culture.

European based candidate

Seeking a challenging and viable position as scientific leader in an innovative, dynamic and professional Biotech company with business exposure.

The candidate is a biotech executive and research scientist with several years’ experience in the management of preclinical research and early development in oncology. Is a highly self-motivated and results-oriented professional with strong presentation, project management and interpersonal skills ideally suited to international project teams.

Based on previous experience in industry, he is able to drive the build-up of strategic pipelines and product development with a high degree of responsibility. Has a strategic mindset coupled with high business awareness and leadership skills, can successfully translate a company’s strategy and vision, thus contributing significantly to sustainable business success.

Qualified with B.Sc. (Hons) Ph.D.

Scientist: Biotechnology

• Scientist interested moving in to the commercial and management aspect of Pharmaceutical/Biotechnology/Commercialisation industry.

• 12 years of experience working in some of the best Australia and USA laboratories. Strong Research Training and Publications in the field of Molecular Biology, Genetics and Biochemistry.

• Technical leadership expertise for various kinds of R&D projects spanning viz, identification of drug candidates to treat Metabolic Disease, Neurological Disease and Cancer. Excellent Project Management experience.

• Experienced Life Science Consultant for USA based pharmaceutical firm.

• Strong networking skills, especially with colleagues from pharmaceutical, biotech, business, commercialisation, sales/marketing and IT sectors.

• Expert Science and Medical Education Trainer for students, technicians and colleagues.

• Grant writing, budgeting and submission experience.

• Expertise in critical thinking, analytical and problem solving skills.Plant Manager

Well versed within technology based industries, with process scale-up, process efficiency, capital and operation budgeting, maintenance operations and environmental sustainability. These skills have been demonstrated across various industries including nano materials, food manufacturing and the supply of products to the pharmaceutical industry.

Practical experience in building relationships across international and cultural borders, particularly in Europe but also North and South America as well as Asia-Pacific, and Africa.

With strong operational skills, have developed a good understanding of how to motivate, influence and manage people by using effective team building, performance management and conflict resolution techniques.

http://tranzition.com.au/Available-Candidates.html



www.lsq.com.au 17

Community Noticeboard

To access all full notices on the Community Noticeboard please visit:

http://www.lsq.com.au/Documents/CommunityNoticeboard.aspx

Thank you to the LSQ Foundation Supporters

QAAFI Science Seminars

Throughout 2014 the Queensland Alliance for

Agriculture and Food Innovation is hosting a

high-profile weekly seminar series across the

disciplines of agriculture, food and nutrition

science. To learn about upcoming seminars,

and to register, click here.

[email protected]

NZACRes 2014 14-15 August 2014 | Auckland, New Zealand

The theme for the 10th Anniversary Conference of NZACRes is People, Passion and Progress. For more details, click here, and to register, click here.

Quality Systems for

Research Laboratories

course

I-20

I n n o v a t i o n - 2 0

Brisbane, Australia

14 November 2014

[email protected]

22-23 October 2014

Brisbane, Queensland

For details, and to register,

please click here, or contact

LSQ at

[email protected]

I-20

I n n o v a t i o n - 2 0

Brisbane, Australia

14 November 2014

[email protected]

Faces of LSQ Campaign

LSQ want to highlight “the faces” of the people who make up the

Life Sciences community, as represented by our Members. We

would appreciate if you could send us a high resolution headshot of

key personnel so we can raise the visibility of your business in future

marketing materials and at international conferences. Please send

images to [email protected].

www.i-20.com.au

Check out the latest

news from Instinctif

- here.

12th Annual Research Australia

Award Dinner - nominations open

The Annual Research Australia

Awards dinner will be held on 5

November 2014. To learn about each

award, and vote, click here.

Food as Medicines Forum 2014

3 July 2014 | Brisbane, Australia.FAM’s opening address will be delivered by the Hon Dr John McVeigh, Minister for Agriculture, Fisheries and Forestry. For more details, or to register, click here.

Biopharmaceutical Development Fund - second round open

Application submission closes on July 31st. For more details, click here.

Discovery & Development of New Pain Medicines: Towards Improving Translational Research Outcomes

Thurs June 19 | San Diego, California

Executive Director, CIPDD/TetraQ, Professor Maree Smith will deliver a presentation on the research effort directed at understanding the neurobiology of chronic pain.

Click here to register.

www.i-20.com.au

www.trx14.com.au

http://www.therqa.com/courses/c5602-quality-systems-for-research-laboratories/

http://www.researchaustralia.org/events/category/2014-awards-dinner

http://instinctif.com/

http://nzacres2014.org.nz/page/registration

http://nzacres2014.org.nz/page/programme

http://www.qaafi.uq.edu.au/qaafi-science-seminars-2014

http://biocom.org/emailmarketer/link.php?M=31870755&N=2758&L=3324&F=H

http://www.biopharmaus.com.au/bdf/

http://online.speedmarketing.com.au/download/files/44272/1743382/FAM%20Forum%20Save%20Date%202014.pdf



www.lsq.com.au 18

Upcoming EventsDate Event

15th-19th June 2014 DIA 2014, San Diego, USA.

19th June 2014 Discovery & Development of New Pain Medicines: Towards Improving Translational Research Outcomes, San Diego, USA.

22nd June 2014 The 5th Annual Burrill Pan-Asia Life Sciences Meeting, San Diego, USA.

23rd - 26th June 2014 BIO 2014, San Diego, USA.

3rd July 2014 Food as Medicine Forum 2014, Springfield, Queensland, Australia.

6th - 10th July 2014 NanoBio Australia, Brisbane, Australia.

23rd - 24th July 2014 BioBusiness Asia, Taipei, Taiwan.

14th - 15th August 2014 NZACRes 2014 10th Anniversary Conference, Auckland, New Zealand.

17th - 20th August 2014 World Congress on Medicinal and Aromatic Plants, Brisbane, Australia.

1st - 6th September 2014 2014 Queensland Small Business Week, Queensland, Australia.

2nd September 2014 LSQ Queensland Small Business Week event: Complementary Medicines and Functional Foods, Brisbane, Australia.

4th September 2014 LSQ Queensland Small Business Week event: Medical Devices, Brisbane, Australia.

8th - 9th September 2014 The 2014 Australian Institute for Tropical Health & Medicine (AITHM) & Queensland Tropical Health Alliance (QTHA) Annual Conference, Cairns, Australia.

22nd - 24th September 2014 BioPharm America, Boston, USA.

5th - 8th October 2014 Agricultural Biotechnology International Conference 2014, Saskatoon, Saskatchewan.

6th - 8th October 2014 AdvaMed 2014, Chicago, USA.

13th October 2014 Connections 2014: From Research to Community, Sydney, Australia.

16th October 2014 The Premier of Queensland’s Export Awards Ceremony, Brisbane, Australia.

17th October 2014 The 2014 LSQ Globally Engaging Networking Event (GENE), Brisbane, Australia.

22nd - 23rd October 2014 Quality Systems for Research Laboratories course, Brisbane, Australia.

24th October 2014 Translational Research Excellence 2014 (TRX14), Brisbane, Australia.

28th - 31st October 2014 AusBiotech 2014, Gold Coast, Australia.

3rd - 5th November 2014 Bio-Europe 2014, Frankfurt, Germany.

14th November 2014 I-20 (Innovation-20), Brisbane, Australia.

For a full listing of events please visit the events calendar on our website.

Photos from previous events are on our website and can be found at Events >> Photos

LSQ means business for its Members

LSQ Foundation Supporters

LSQ Members

Discovery and preclinical linking tool

BUSINESS & TECHNOLOGY PRECINCTSInstitute for GlycomicsGriffith Health InstituteEskitis InstituteGriffith Enterprise

LSQ Foundation Supporters

your other life partner

proudly supported by

LSQ means business for its Members

www.lsq.com.au

Where industry stakeholders

come together and cooperate to grow their businesses

Advocacy and Representation

Financial Benefits

Promotion and Marketing

Strategic Alliances

around the World

NetworkingBusiness Development

Life Sciences Queensland Limited Quarterly Newsletter ...€¦ · Life Sciences Queensland Limited...

Documents

Transcript of Life Sciences Queensland Limited Quarterly Newsletter ...€¦ · Life Sciences Queensland Limited...